Sapiens International (SPNS) Q1 2025 earnings summary

Executive summary

• Q1 2025 revenue reached $136.1M, up 1.4% year-over-year, with strong momentum in Life & Annuity (L&A) and expansion in APAC and Europe.

• Announced and closed two strategic acquisitions: Candela (APAC life automation) and AdvantageGo (global P&C underwriting workbench), expanding product offerings and global reach.

• Continued investment in AI-driven insurance platforms, SaaS/cloud migration, and cross-selling, with a robust pipeline and focus on global expansion.

• Annualized recurring revenue (ARR) grew 11.8% year-over-year, reflecting strong business stickiness.

• 2025 revenue guidance was raised, but operating profit guidance was revised downward due to acquisition impacts.

Financial highlights

• Q1 2025 revenue was $136.1M, up 1.4% year-over-year; constant currency revenue would have been higher.

• Gross profit was $63M (gross margin 46.3%, up 90 bps year-over-year); net income attributable to shareholders was $21M, up 1.3% year-over-year; EPS was $0.37.

• Operating profit was $25M (operating margin 18%); adjusted EBITDA reached $25.5M.

• Adjusted free cash flow was $23M, up from $17M in Q1 2024.

• Cash and equivalents plus short-term deposits at $206M; debt at $20M as of March 31, 2025.

Outlook and guidance

• 2025 non-GAAP revenue guidance raised to $574M–$578M (6% growth at midpoint); non-GAAP operating profit expected at $94M–$96M (16.5% margin), revised downward due to acquisition impacts.

• Q2 2025 operating profit expected at $20M–$21M.

• 2026 revenue growth expected in mid to high single digits, with profitability improvements.

• Guidance reflects favorable currency movements, offset by ~$5M negative impact from acquisitions and integration costs.

• Focus areas for growth include new logo acquisition, cross-sell, cloud/SaaS transition, and M&A.